Literature DB >> 10196332

Polyvalent Rev decoys act as artificial Rev-responsive elements.

T L Symensma1, S Baskerville, A Yan, A D Ellington.   

Abstract

Interactions between Rev and the Rev-responsive element (RRE) control the order, rate, and extent of gene expression in human immunodeficiency virus type 1. Rev decoys may therefore prove to be useful RNA therapeutics for the treatment of AIDS. To improve upon the current generation of Rev decoys that bind single Rev molecules, it would be useful to generate polyvalent Rev decoys that could bind multiple Rev molecules. J. Kjems and P. A. Sharp (J. Virol. 67:4769-4776, 1993) originally constructed functional polyvalent Rev decoys, but the structural context of these polyvalent decoys remains unclear, and it has been argued that the individual decoys were either structurally discrete (Kjems and Sharp, J. Virol. 67:4769-4776, 1993) or were part of an extended helix (R. W. Zemmel et al., Mol. Biol. 258:763-777, 1996). To resolve the differences between these models, we have designed and synthesized concatemers of Rev-binding elements (RBEs) that fold to form multiple, discrete, high-affinity Rev-binding sites. We find that the concatenated RBEs can facilitate the cytoplasmic transport of viral mRNAs and therefore likely bind multiple Rev molecules. These artificial RREs may simultaneously sequester Rev and hinder access to the cellular transport machinery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196332      PMCID: PMC104215     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Interaction of the HIV-1 rev cofactor eukaryotic initiation factor 5A with ribosomal protein L5.

Authors:  O Schatz; M Oft; C Dascher; M Schebesta; O Rosorius; H Jaksche; M Dobrovnik; D Bevec; J Hauber
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 2.  Nuclear export signals and the fast track to the cytoplasm.

Authors:  L Gerace
Journal:  Cell       Date:  1995-08-11       Impact factor: 41.582

3.  A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.

Authors:  N Yuyama; J Ohkawa; T Koguma; M Shirai; K Taira
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

4.  Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.

Authors:  S W Lee; H F Gallardo; E Gilboa; C Smith
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes.

Authors:  C Zhou; I C Bahner; G P Larson; J A Zaia; J J Rossi; E B Kohn
Journal:  Gene       Date:  1994-11-04       Impact factor: 3.688

6.  The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm.

Authors:  B E Meyer; M H Malim
Journal:  Genes Dev       Date:  1994-07-01       Impact factor: 11.361

7.  In vitro evolution of functional nucleic acids: high-affinity RNA ligands of HIV-1 proteins.

Authors:  C Tuerk; S MacDougal-Waugh
Journal:  Gene       Date:  1993-12-27       Impact factor: 3.688

8.  HIV-1 Rev is capable of shuttling between the nucleus and cytoplasm.

Authors:  N Richard; S Iacampo; A Cochrane
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

9.  Reduction in replication of the human immunodeficiency virus type 1 in human T cell lines by polymerase III-driven transcription of chimeric tRNA-antisense RNA genes.

Authors:  U Junker; K Rittner; M Homann; D Bevec; E Böhnlein; G Sczakiel
Journal:  Antisense Res Dev       Date:  1994

10.  Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA.

Authors:  U Fischer; S Meyer; M Teufel; C Heckel; R Lührmann; G Rautmann
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

View more
  11 in total

1.  Molecular recognition of HIV-1 RNAs with branched peptides.

Authors:  Ashley N Peralta; Yumin Dai; Chringma Sherpa; Stuart F J Le Grice; Webster L Santos
Journal:  Methods Enzymol       Date:  2019-05-15       Impact factor: 1.600

2.  A reporter based single step assay for evaluation of inhibitors targeting HIV-1 Rev-RRE interaction.

Authors:  Sumeer Raina; Ajit G Chande; Masanori Baba; Robin Mukhopadhyaya
Journal:  Virusdisease       Date:  2013-09-27

3.  Musashi1 Impacts Radio-Resistance in Glioblastoma by Controlling DNA-Protein Kinase Catalytic Subunit.

Authors:  Patricia Rosa de Araujo; Aparna Gorthi; Acarizia E da Silva; Sonal S Tonapi; Dat T Vo; Suzanne C Burns; Mei Qiao; Philip J Uren; Zhi-Min Yuan; Alexander J R Bishop; Luiz O F Penalva
Journal:  Am J Pathol       Date:  2016-07-25       Impact factor: 4.307

4.  Discovery of a Branched Peptide That Recognizes the Rev Response Element (RRE) RNA and Blocks HIV-1 Replication.

Authors:  Yumin Dai; Jessica E Wynn; Ashley N Peralta; Chringma Sherpa; Bhargavi Jayaraman; Hao Li; Astha Verma; Alan D Frankel; Stuart F Le Grice; Webster L Santos
Journal:  J Med Chem       Date:  2018-10-18       Impact factor: 7.446

5.  A solution to limited genomic capacity: using adaptable binding surfaces to assemble the functional HIV Rev oligomer on RNA.

Authors:  Matthew D Daugherty; Iván D'Orso; Alan D Frankel
Journal:  Mol Cell       Date:  2008-09-26       Impact factor: 17.970

6.  Heterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication.

Authors:  Deidra Shuck-Lee; Fei Fei Chen; Ryan Willard; Sharmila Raman; Roger Ptak; Marie-Louise Hammarskjold; David Rekosh
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

7.  Characterization and in vitro activity of a branched peptide boronic acid that interacts with HIV-1 RRE RNA.

Authors:  Jessica E Wynn; Wenyu Zhang; Denis M Tebit; Laurie R Gray; Marie-Louise Hammarskjold; David Rekosh; Webster L Santos
Journal:  Bioorg Med Chem       Date:  2016-04-05       Impact factor: 3.641

8.  Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).

Authors:  Pheroze Joshi; Vinayaka R Prasad
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Targeting folded RNA: a branched peptide boronic acid that binds to a large surface area of HIV-1 RRE RNA.

Authors:  Wenyu Zhang; David I Bryson; Jason B Crumpton; Jessica Wynn; Webster L Santos
Journal:  Org Biomol Chem       Date:  2013-10-07       Impact factor: 3.876

10.  The HIV-1 Rev response element: an RNA scaffold that directs the cooperative assembly of a homo-oligomeric ribonucleoprotein complex.

Authors:  Jason Fernandes; Bhargavi Jayaraman; Alan Frankel
Journal:  RNA Biol       Date:  2012-01-01       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.